nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—EGFR—chronic obstructive pulmonary disease	0.526	1	CbGaD
Docetaxel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.013	0.215	CbGbCtD
Docetaxel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00876	0.145	CbGbCtD
Docetaxel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00836	0.139	CbGbCtD
Docetaxel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00745	0.124	CbGbCtD
Docetaxel—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0073	0.121	CbGbCtD
Docetaxel—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00689	0.114	CbGbCtD
Docetaxel—KIF11—respiratory system—chronic obstructive pulmonary disease	0.00564	0.0707	CbGeAlD
Docetaxel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00437	0.0726	CbGbCtD
Docetaxel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00413	0.0685	CbGbCtD
Docetaxel—KIF11—lung—chronic obstructive pulmonary disease	0.00299	0.0375	CbGeAlD
Docetaxel—MAP4—respiratory system—chronic obstructive pulmonary disease	0.0026	0.0326	CbGeAlD
Docetaxel—TUBB3—respiratory system—chronic obstructive pulmonary disease	0.0026	0.0326	CbGeAlD
Docetaxel—BCL2—respiratory system—chronic obstructive pulmonary disease	0.00236	0.0296	CbGeAlD
Docetaxel—MAP4—connective tissue—chronic obstructive pulmonary disease	0.00229	0.0287	CbGeAlD
Docetaxel—TUBB3—connective tissue—chronic obstructive pulmonary disease	0.00229	0.0287	CbGeAlD
Docetaxel—BCL2—connective tissue—chronic obstructive pulmonary disease	0.00208	0.0261	CbGeAlD
Docetaxel—MAP2—respiratory system—chronic obstructive pulmonary disease	0.00205	0.0257	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—chronic obstructive pulmonary disease	0.0019	0.0239	CbGeAlD
Docetaxel—MAP2—bronchus—chronic obstructive pulmonary disease	0.00168	0.0211	CbGeAlD
Docetaxel—TUBB4A—respiratory system—chronic obstructive pulmonary disease	0.00158	0.0198	CbGeAlD
Docetaxel—TUBB2B—respiratory system—chronic obstructive pulmonary disease	0.00153	0.0192	CbGeAlD
Docetaxel—MAP2—trachea—chronic obstructive pulmonary disease	0.00151	0.019	CbGeAlD
Docetaxel—TUBB2A—respiratory system—chronic obstructive pulmonary disease	0.00144	0.018	CbGeAlD
Docetaxel—TUBB6—respiratory system—chronic obstructive pulmonary disease	0.00142	0.0178	CbGeAlD
Docetaxel—TUBB4A—connective tissue—chronic obstructive pulmonary disease	0.00139	0.0175	CbGeAlD
Docetaxel—TUBB3—lung—chronic obstructive pulmonary disease	0.00138	0.0173	CbGeAlD
Docetaxel—MAP4—lung—chronic obstructive pulmonary disease	0.00138	0.0173	CbGeAlD
Docetaxel—TUBB2B—connective tissue—chronic obstructive pulmonary disease	0.00135	0.0169	CbGeAlD
Docetaxel—TUBB2A—connective tissue—chronic obstructive pulmonary disease	0.00127	0.0159	CbGeAlD
Docetaxel—TUBB2B—bronchus—chronic obstructive pulmonary disease	0.00126	0.0158	CbGeAlD
Docetaxel—BCL2—lung—chronic obstructive pulmonary disease	0.00125	0.0157	CbGeAlD
Docetaxel—EGFR—lung—chronic obstructive pulmonary disease	0.00124	0.0155	CbGeAlD
Docetaxel—TUBB4B—respiratory system—chronic obstructive pulmonary disease	0.00123	0.0155	CbGeAlD
Docetaxel—SLCO1B3—lung—chronic obstructive pulmonary disease	0.00121	0.0152	CbGeAlD
Docetaxel—TUBB—bronchus—chronic obstructive pulmonary disease	0.00119	0.0149	CbGeAlD
Docetaxel—TUBB2A—bronchus—chronic obstructive pulmonary disease	0.00118	0.0148	CbGeAlD
Docetaxel—TUBB6—bronchus—chronic obstructive pulmonary disease	0.00117	0.0146	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00116	0.0146	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00116	0.0145	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—chronic obstructive pulmonary disease	0.00114	0.0143	CbGeAlD
Docetaxel—TUBB2B—trachea—chronic obstructive pulmonary disease	0.00113	0.0142	CbGeAlD
Docetaxel—MAP2—lung—chronic obstructive pulmonary disease	0.00109	0.0136	CbGeAlD
Docetaxel—TUBB4B—connective tissue—chronic obstructive pulmonary disease	0.00109	0.0136	CbGeAlD
Docetaxel—TUBB—trachea—chronic obstructive pulmonary disease	0.00107	0.0134	CbGeAlD
Docetaxel—TUBB2A—trachea—chronic obstructive pulmonary disease	0.00106	0.0133	CbGeAlD
Docetaxel—TUBB6—trachea—chronic obstructive pulmonary disease	0.00105	0.0132	CbGeAlD
Docetaxel—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00102	0.0128	CbGeAlD
Docetaxel—TUBB4B—bronchus—chronic obstructive pulmonary disease	0.00101	0.0127	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000993	0.0125	CbGeAlD
Docetaxel—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.000977	0.0123	CbGeAlD
Docetaxel—ABCC10—trachea—chronic obstructive pulmonary disease	0.000918	0.0115	CbGeAlD
Docetaxel—TUBB4B—trachea—chronic obstructive pulmonary disease	0.000911	0.0114	CbGeAlD
Docetaxel—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.00086	0.0108	CbGeAlD
Docetaxel—TUBB4A—lung—chronic obstructive pulmonary disease	0.00084	0.0105	CbGeAlD
Docetaxel—TUBB2B—lung—chronic obstructive pulmonary disease	0.000811	0.0102	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000787	0.00987	CbGeAlD
Docetaxel—TUBB—lung—chronic obstructive pulmonary disease	0.000768	0.00963	CbGeAlD
Docetaxel—TUBB2A—lung—chronic obstructive pulmonary disease	0.000764	0.00958	CbGeAlD
Docetaxel—TUBB6—lung—chronic obstructive pulmonary disease	0.000753	0.00945	CbGeAlD
Docetaxel—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000723	0.00907	CbGeAlD
Docetaxel—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000675	0.00847	CbGeAlD
Docetaxel—ABCC10—lung—chronic obstructive pulmonary disease	0.00066	0.00827	CbGeAlD
Docetaxel—TUBB4B—lung—chronic obstructive pulmonary disease	0.000655	0.00821	CbGeAlD
Docetaxel—ABCC1—trachea—chronic obstructive pulmonary disease	0.000649	0.00814	CbGeAlD
Docetaxel—CYP1B1—lung—chronic obstructive pulmonary disease	0.000519	0.00651	CbGeAlD
Docetaxel—ABCC1—lung—chronic obstructive pulmonary disease	0.000466	0.00585	CbGeAlD
Docetaxel—ABCG2—lung—chronic obstructive pulmonary disease	0.000386	0.00484	CbGeAlD
Docetaxel—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000359	0.0045	CbGeAlD
Docetaxel—CYP3A5—lung—chronic obstructive pulmonary disease	0.000358	0.0045	CbGeAlD
Docetaxel—ABCB1—trachea—chronic obstructive pulmonary disease	0.000265	0.00332	CbGeAlD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Docetaxel—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Docetaxel—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Docetaxel—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Docetaxel—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Docetaxel—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Docetaxel—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Docetaxel—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00111	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00111	CcSEcCtD
Docetaxel—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00111	CcSEcCtD
Docetaxel—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00111	CcSEcCtD
Docetaxel—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00111	CcSEcCtD
Docetaxel—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000228	0.0011	CcSEcCtD
Docetaxel—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Docetaxel—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Docetaxel—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Docetaxel—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.0011	CcSEcCtD
Docetaxel—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00109	CcSEcCtD
Docetaxel—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00109	CcSEcCtD
Docetaxel—Infection—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00109	CcSEcCtD
Docetaxel—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Docetaxel—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Docetaxel—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00108	CcSEcCtD
Docetaxel—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Docetaxel—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Docetaxel—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Docetaxel—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Docetaxel—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Docetaxel—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00107	CcSEcCtD
Docetaxel—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Docetaxel—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Docetaxel—Infection—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Docetaxel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00106	CcSEcCtD
Docetaxel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00106	CcSEcCtD
Docetaxel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00106	CcSEcCtD
Docetaxel—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00106	CcSEcCtD
Docetaxel—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Docetaxel—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Docetaxel—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00105	CcSEcCtD
Docetaxel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00104	CcSEcCtD
Docetaxel—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00104	CcSEcCtD
Docetaxel—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00104	CcSEcCtD
Docetaxel—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00103	CcSEcCtD
Docetaxel—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Docetaxel—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00102	CcSEcCtD
Docetaxel—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Docetaxel—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Docetaxel—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Docetaxel—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Docetaxel—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00101	CcSEcCtD
Docetaxel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Docetaxel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.001	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.000999	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000206	0.000999	CcSEcCtD
Docetaxel—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.000991	CcSEcCtD
Docetaxel—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.000991	CcSEcCtD
Docetaxel—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000987	CcSEcCtD
Docetaxel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.000985	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000202	0.000978	CcSEcCtD
Docetaxel—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000977	CcSEcCtD
Docetaxel—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000977	CcSEcCtD
Docetaxel—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.000975	CcSEcCtD
Docetaxel—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000201	0.000975	CcSEcCtD
Docetaxel—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.000971	CcSEcCtD
Docetaxel—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000968	CcSEcCtD
Docetaxel—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000967	CcSEcCtD
Docetaxel—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000965	CcSEcCtD
Docetaxel—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000965	CcSEcCtD
Docetaxel—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000964	CcSEcCtD
Docetaxel—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000961	CcSEcCtD
Docetaxel—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000197	0.000955	CcSEcCtD
Docetaxel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000197	0.000952	CcSEcCtD
Docetaxel—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00095	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000946	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000946	CcSEcCtD
Docetaxel—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000945	CcSEcCtD
Docetaxel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000945	CcSEcCtD
Docetaxel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000945	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000943	CcSEcCtD
Docetaxel—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000937	CcSEcCtD
Docetaxel—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000937	CcSEcCtD
Docetaxel—Pain—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000937	CcSEcCtD
Docetaxel—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000937	CcSEcCtD
Docetaxel—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000936	CcSEcCtD
Docetaxel—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000929	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000927	CcSEcCtD
Docetaxel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000926	CcSEcCtD
Docetaxel—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000923	CcSEcCtD
Docetaxel—ABCB1—lung—chronic obstructive pulmonary disease	0.00019	0.00239	CbGeAlD
Docetaxel—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00092	CcSEcCtD
Docetaxel—Pain—Montelukast—chronic obstructive pulmonary disease	0.00019	0.000918	CcSEcCtD
Docetaxel—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000918	CcSEcCtD
Docetaxel—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.000916	CcSEcCtD
Docetaxel—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000912	CcSEcCtD
Docetaxel—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000912	CcSEcCtD
Docetaxel—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000911	CcSEcCtD
Docetaxel—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.000908	CcSEcCtD
Docetaxel—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.000907	CcSEcCtD
Docetaxel—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000905	CcSEcCtD
Docetaxel—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000903	CcSEcCtD
Docetaxel—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000903	CcSEcCtD
Docetaxel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.000902	CcSEcCtD
Docetaxel—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.0009	CcSEcCtD
Docetaxel—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000899	CcSEcCtD
Docetaxel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.000898	CcSEcCtD
Docetaxel—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000896	CcSEcCtD
Docetaxel—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000896	CcSEcCtD
Docetaxel—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000896	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000894	CcSEcCtD
Docetaxel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000892	CcSEcCtD
Docetaxel—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000885	CcSEcCtD
Docetaxel—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000885	CcSEcCtD
Docetaxel—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000878	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000878	CcSEcCtD
Docetaxel—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000867	CcSEcCtD
Docetaxel—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000867	CcSEcCtD
Docetaxel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000867	CcSEcCtD
Docetaxel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000867	CcSEcCtD
Docetaxel—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.000864	CcSEcCtD
Docetaxel—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.000856	CcSEcCtD
Docetaxel—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.000856	CcSEcCtD
Docetaxel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.000856	CcSEcCtD
Docetaxel—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000853	CcSEcCtD
Docetaxel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000851	CcSEcCtD
Docetaxel—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000849	CcSEcCtD
Docetaxel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000849	CcSEcCtD
Docetaxel—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000846	CcSEcCtD
Docetaxel—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00084	CcSEcCtD
Docetaxel—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000836	CcSEcCtD
Docetaxel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000818	CcSEcCtD
Docetaxel—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000818	CcSEcCtD
Docetaxel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000808	CcSEcCtD
Docetaxel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000808	CcSEcCtD
Docetaxel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.000807	CcSEcCtD
Docetaxel—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000805	CcSEcCtD
Docetaxel—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000805	CcSEcCtD
Docetaxel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000791	CcSEcCtD
Docetaxel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000786	CcSEcCtD
Docetaxel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000786	CcSEcCtD
Docetaxel—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000776	CcSEcCtD
Docetaxel—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000776	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000774	CcSEcCtD
Docetaxel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00077	CcSEcCtD
Docetaxel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000763	CcSEcCtD
Docetaxel—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00076	CcSEcCtD
Docetaxel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00075	CcSEcCtD
Docetaxel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00075	CcSEcCtD
Docetaxel—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000746	CcSEcCtD
Docetaxel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000743	CcSEcCtD
Docetaxel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000735	CcSEcCtD
Docetaxel—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000732	CcSEcCtD
Docetaxel—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000727	CcSEcCtD
Docetaxel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000725	CcSEcCtD
Docetaxel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000725	CcSEcCtD
Docetaxel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00071	CcSEcCtD
Docetaxel—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000709	CcSEcCtD
Docetaxel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000708	CcSEcCtD
Docetaxel—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000697	CcSEcCtD
Docetaxel—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000697	CcSEcCtD
Docetaxel—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000691	CcSEcCtD
Docetaxel—Rash—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000691	CcSEcCtD
Docetaxel—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000691	CcSEcCtD
Docetaxel—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000691	CcSEcCtD
Docetaxel—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00069	CcSEcCtD
Docetaxel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000687	CcSEcCtD
Docetaxel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000687	CcSEcCtD
Docetaxel—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000686	CcSEcCtD
Docetaxel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000684	CcSEcCtD
Docetaxel—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000683	CcSEcCtD
Docetaxel—Rash—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000677	CcSEcCtD
Docetaxel—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000676	CcSEcCtD
Docetaxel—Headache—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000673	CcSEcCtD
Docetaxel—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000667	CcSEcCtD
Docetaxel—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000663	CcSEcCtD
Docetaxel—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000663	CcSEcCtD
Docetaxel—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000658	CcSEcCtD
Docetaxel—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000653	CcSEcCtD
Docetaxel—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000652	CcSEcCtD
Docetaxel—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000652	CcSEcCtD
Docetaxel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000651	CcSEcCtD
Docetaxel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000651	CcSEcCtD
Docetaxel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000648	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000639	CcSEcCtD
Docetaxel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000638	CcSEcCtD
Docetaxel—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00063	CcSEcCtD
Docetaxel—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000628	CcSEcCtD
Docetaxel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000615	CcSEcCtD
Docetaxel—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00061	CcSEcCtD
Docetaxel—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000607	CcSEcCtD
Docetaxel—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000597	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000594	CcSEcCtD
Docetaxel—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000594	CcSEcCtD
Docetaxel—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000584	CcSEcCtD
Docetaxel—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000579	CcSEcCtD
Docetaxel—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000567	CcSEcCtD
Docetaxel—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000564	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000551	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000548	CcSEcCtD
Docetaxel—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000542	CcSEcCtD
Docetaxel—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000537	CcSEcCtD
Docetaxel—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000537	CcSEcCtD
Docetaxel—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000533	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000532	CcSEcCtD
Docetaxel—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000529	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000529	CcSEcCtD
Docetaxel—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000508	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000489	CcSEcCtD
Docetaxel—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000489	CcSEcCtD
Docetaxel—Syncope—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000474	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000465	CcSEcCtD
Docetaxel—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000458	CcSEcCtD
Docetaxel—Hypertension—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.000456	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00045	CcSEcCtD
Docetaxel—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00045	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000447	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.000437	CcSEcCtD
Docetaxel—Oedema—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000431	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000431	CcSEcCtD
Docetaxel—Infection—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000429	CcSEcCtD
Docetaxel—Shock—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000424	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.000423	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000421	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.000419	CcSEcCtD
Docetaxel—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000411	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000393	CcSEcCtD
Docetaxel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.11e-05	0.000393	CcSEcCtD
Docetaxel—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.00039	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000387	CcSEcCtD
Docetaxel—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.00038	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000375	CcSEcCtD
Docetaxel—Rash—Prednisolone—chronic obstructive pulmonary disease	7.73e-05	0.000374	CcSEcCtD
Docetaxel—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.72e-05	0.000374	CcSEcCtD
Docetaxel—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000372	CcSEcCtD
Docetaxel—Headache—Prednisolone—chronic obstructive pulmonary disease	7.68e-05	0.000372	CcSEcCtD
Docetaxel—Constipation—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000369	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000355	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000353	CcSEcCtD
Docetaxel—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.28e-05	0.000353	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000341	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000341	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000318	CcSEcCtD
Docetaxel—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.00031	CcSEcCtD
Docetaxel—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.3e-05	0.000305	CcSEcCtD
Docetaxel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000295	CcSEcCtD
Docetaxel—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000285	CcSEcCtD
Docetaxel—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.000274	CcSEcCtD
Docetaxel—Rash—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000272	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000272	CcSEcCtD
Docetaxel—Headache—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.00027	CcSEcCtD
Docetaxel—Nausea—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000256	CcSEcCtD
Docetaxel—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.36e-05	0.000263	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	3.35e-05	0.000262	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	3.35e-05	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KL—chronic obstructive pulmonary disease	3.31e-05	0.000259	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL6—chronic obstructive pulmonary disease	3.25e-05	0.000254	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.23e-05	0.000252	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.18e-05	0.000249	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.16e-05	0.000247	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.15e-05	0.000246	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.13e-05	0.000244	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.000244	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.11e-05	0.000243	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.09e-05	0.000241	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.07e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	3.07e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	3.07e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	3.03e-05	0.000237	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.03e-05	0.000237	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.02e-05	0.000236	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3e-05	0.000234	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.98e-05	0.000233	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.97e-05	0.000232	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.97e-05	0.000232	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.96e-05	0.000231	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.95e-05	0.00023	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	2.93e-05	0.000229	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.89e-05	0.000226	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.88e-05	0.000225	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	2.87e-05	0.000224	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.87e-05	0.000224	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.86e-05	0.000223	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.85e-05	0.000222	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.83e-05	0.000222	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.82e-05	0.000221	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.78e-05	0.000217	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.77e-05	0.000217	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000216	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.75e-05	0.000215	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000215	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000215	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—chronic obstructive pulmonary disease	2.74e-05	0.000214	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.71e-05	0.000212	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.71e-05	0.000211	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.69e-05	0.00021	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	2.67e-05	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	2.66e-05	0.000208	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.65e-05	0.000207	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.62e-05	0.000204	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.61e-05	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.59e-05	0.000202	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.59e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	2.58e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	2.55e-05	0.000199	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB3—chronic obstructive pulmonary disease	2.54e-05	0.000199	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.53e-05	0.000198	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2.51e-05	0.000196	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.5e-05	0.000196	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.5e-05	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	2.48e-05	0.000194	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000194	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.47e-05	0.000193	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.44e-05	0.00019	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.43e-05	0.00019	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	2.39e-05	0.000187	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	2.38e-05	0.000186	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.37e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	2.37e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.37e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.36e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	2.36e-05	0.000184	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.33e-05	0.000182	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CRP—chronic obstructive pulmonary disease	2.33e-05	0.000182	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.28e-05	0.000178	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.27e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	2.26e-05	0.000177	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.26e-05	0.000177	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—chronic obstructive pulmonary disease	2.23e-05	0.000174	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.23e-05	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000173	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000173	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000173	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.2e-05	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	2.18e-05	0.00017	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.00017	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	2.17e-05	0.00017	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.16e-05	0.000169	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR2—chronic obstructive pulmonary disease	2.13e-05	0.000167	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	2.11e-05	0.000165	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.11e-05	0.000165	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.08e-05	0.000163	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000161	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.04e-05	0.000159	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.04e-05	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.03e-05	0.000158	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KL—chronic obstructive pulmonary disease	2.01e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Disease—HDAC2—chronic obstructive pulmonary disease	1.99e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—chronic obstructive pulmonary disease	1.98e-05	0.000155	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	1.97e-05	0.000154	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KL—chronic obstructive pulmonary disease	1.97e-05	0.000154	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.95e-05	0.000153	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.94e-05	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.91e-05	0.000149	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.9e-05	0.000148	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.9e-05	0.000148	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.000148	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.89e-05	0.000147	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.88e-05	0.000147	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.87e-05	0.000146	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Disease—KL—chronic obstructive pulmonary disease	1.85e-05	0.000145	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000144	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000144	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000144	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000143	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.000143	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000142	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.81e-05	0.000142	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000141	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.79e-05	0.00014	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.79e-05	0.00014	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.75e-05	0.000137	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000137	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.71e-05	0.000133	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000132	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.000131	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.00013	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.64e-05	0.000128	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—chronic obstructive pulmonary disease	1.62e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.58e-05	0.000124	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.57e-05	0.000123	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.00012	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000119	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.52e-05	0.000119	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.51e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB3—chronic obstructive pulmonary disease	1.5e-05	0.000118	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.47e-05	0.000115	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.000114	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.46e-05	0.000114	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.46e-05	0.000114	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—chronic obstructive pulmonary disease	1.45e-05	0.000113	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.44e-05	0.000113	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.41e-05	0.00011	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.4e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.4e-05	0.000109	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB3—chronic obstructive pulmonary disease	1.39e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—chronic obstructive pulmonary disease	1.38e-05	0.000107	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.37e-05	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000107	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.34e-05	0.000105	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—chronic obstructive pulmonary disease	1.32e-05	0.000103	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000103	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.31e-05	0.000102	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.3e-05	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.3e-05	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000101	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.0001	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	9.95e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	9.94e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-05	9.9e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	9.81e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	9.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.23e-05	9.6e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	9.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.21e-05	9.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	9.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.2e-05	9.36e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	9.23e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	9.15e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.17e-05	9.14e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.16e-05	9.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS2—chronic obstructive pulmonary disease	1.16e-05	9.05e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.15e-05	9e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	8.83e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	8.75e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	8.67e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—chronic obstructive pulmonary disease	1.11e-05	8.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	8.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	8.36e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	8.21e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	8.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	7.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.91e-06	7.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	9.88e-06	7.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.79e-06	7.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.77e-06	7.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—chronic obstructive pulmonary disease	9.75e-06	7.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.72e-06	7.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.36e-06	7.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS3—chronic obstructive pulmonary disease	9.31e-06	7.27e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.21e-06	7.19e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.08e-06	7.09e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.04e-06	7.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.78e-06	6.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.7e-06	6.8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	8.65e-06	6.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.62e-06	6.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—chronic obstructive pulmonary disease	8.58e-06	6.7e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—chronic obstructive pulmonary disease	8.5e-06	6.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.46e-06	6.61e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.36e-06	6.54e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.33e-06	6.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.27e-06	6.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.02e-06	6.27e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	8e-06	6.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	7.61e-06	5.95e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.54e-06	5.89e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.28e-06	5.69e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.21e-06	5.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.95e-06	5.43e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.85e-06	5.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.83e-06	5.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	6.53e-06	5.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.52e-06	5.09e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	6.4e-06	5e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.38e-06	4.99e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.17e-06	4.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—chronic obstructive pulmonary disease	6.15e-06	4.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.1e-06	4.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.05e-06	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.78e-06	4.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.57e-06	4.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.5e-06	4.3e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.45e-06	4.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.23e-06	4.09e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.21e-06	4.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.13e-06	4.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—chronic obstructive pulmonary disease	5.02e-06	3.93e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	4.92e-06	3.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.7e-06	3.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—chronic obstructive pulmonary disease	4.64e-06	3.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.31e-06	3.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.28e-06	3.34e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.22e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	3.21e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	3.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.93e-06	3.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.73e-06	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.55e-06	2.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.25e-06	2.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.53e-06	1.98e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.42e-06	1.89e-05	CbGpPWpGaD
